Aminoacyl nucleosides derived from the tumour inhibitor, 1-aminocyclopentanecarboxylic acid.
D000535:Aluminum; D000596:Amino Acids; D000818:Animals; D000970:Antineoplastic Agents; D001593:Benzyl Compounds; D002247:Carbon Isotopes; D002384:Catalysis; D055598:Chemical Phenomena; D002621:Chemistry; D002854:Chromatography, Paper; D002855:Chromatography, Thin Layer; D003517:Cyclopentanes; D004355:Drug Stability; D004586:Electrophoresis; D004926:Escherichia coli / Q000187:drug effects; D004952:Esters / Q000138:chemical synthesis; D006207:Half-Life; D006859:Hydrogen; D006868:Hydrolysis; D007930:Leucine / Q000378:metabolism; D009682:Magnetic Resonance Spectroscopy; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009705:Nucleosides / Q000138:chemical synthesis*; D010084:Oxidation-Reduction; D010087:Oxides; D010954:Plasmacytoma / Q000188:drug therapy; D014176:Protein Biosynthesis; D013237:Stereoisomerism; D014316:Tritium; D014529:Uridine; D014633:Valine / Q000378:metabolism
D000596:Amino Acids; D000970:Antineoplastic Agents; D001593:Benzyl Compounds; D002247:Carbon Isotopes; D003517:Cyclopentanes; D004952:Esters; D009705:Nucleosides; D010087:Oxides; D014316:Tritium; D006859:Hydrogen; D000535:Aluminum; D007930:Leucine; D014633:Valine; D014529:Uridine